Gain Therapeutics, Inc.·4

Oct 3, 4:36 PM ET

Alder Matthias 4

4 · Gain Therapeutics, Inc. · Filed Oct 3, 2023

Insider Transaction Report

Form 4
Period: 2023-10-01
Alder Matthias
CHIEF OPERATING OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2023-10-01+8256,675 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-10-018259,075 total
    Common Stock (825 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
  • [F2]The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION